Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (4): 468-470    DOI: 10.12891/ceog17772014
Case Report Previous articles | Next articles
Transient sixth cranial nerve palsy following orgasm abrogated by treatment with sympathomimetic amines
J.H. Check1, *(), B. Katsoff2
1Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, New Jersey
2Temple University School of Medicine, Department of Medicine, Philadelphia, Pennsylvania (USA)
Download:  PDF(54KB)  ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To describe a unique disorder where a transient 6th nerve palsy leading to diploplia following orgasm developed in a 28- year- old woman. This coincided with a weight gain of 100 pounds in a short time without a corresponding change in dietary habits. Materials and Methods: She was treated with the sympathomimetic amine dextroamphetamine sulfate. Results: Indeed she immediately responded to treatment with dextroamphetamine sulfate sustained release capsules with complete resolution of the episodes of 6th nerve palsy following orgasm. Conclusions: The main importance of this case is that it suggests that orgasm causes a transient generalized decrease in sympathetic nervous system activity and that the achievement of an orgasm may require an increase in the sympathetic nervous system activity.
Key words:  Sixth cranial nerve palsy      Diplopia      Orgasm      Sympathetic nervous system hypofunction      Dextroamphetamine sulfate     
Published:  10 August 2014     
*Corresponding Author(s):  J.H. CHECK     E-mail:  laurie@ccivf.com

Cite this article: 

J.H. Check, B. Katsoff. Transient sixth cranial nerve palsy following orgasm abrogated by treatment with sympathomimetic amines. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(4): 468-470.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog17772014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I4/468

[1] J.H. Check, D. Check, R. Cohen. A novel effective treatment for menière’s disease – dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 807-809.
[2] J.H. Check, D. Check. The increased cellular permeability syndrome manifesting as severe idiopathic type urinary incontinence[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 812-814.
[3] J.H. Check, R. Cohen. Sympathomimetic amine therapy abrogates severe long-term unexpalined abdominal pain and diarrhea (microscopic colitis) - possible infertility implications[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 489-491.
[4] J.H. Check, D.L. Check, M.P. Dougherty. Marked improvement of the aromatase induced arthralgia syndrome following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 291-292.
[5] J.H. Check, M.P. Dougherty, D.L. Check. Long standing post-herpetic neuralgia resistant to standard anti-neuropathy medication showing quick dramatic improvement following treatment with sympathomimetic amines[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 335-336.
[6] J.H. Check, M. Citerone, T. Citerone. The increased cellular permeability syndrome as a cause of traumatic stuttering[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 773-774.
[7] J.H. Check. Changing the name of a syndrome: sympathetic neural hyperalgesia edema syndrome becomes – the increased cellular permeability syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 819-823.
[8] J.H. Check, R. Cohen. Amelioration of severe generalized idiopathic pruritus in an estrogen deficient woman taking an aromatase inhibitor for breast cancer following treatment with amphetamine salts[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 934-935.
[9] J. H. Check, R. Cohen. Marked improvement of severe gastroparesis following high dosage, but very well tolerated, dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 611-612.
[10] J.H. Check, A. Jaffe. Dextroamphetamine sulfate provided quick relief of severe post-partum depression that was recalcitrant to standard antidepressants and psychotherapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 272-274.
[11] J.H. Check. Chronic unremitting lower abdominal pain quickly abrogated following treatment with amphetamine[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 109-111.
[12] J.H. Check, A. Jaffe. Resolution of pelvic pain related to adenomyosis following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 671-672.
[13] J.H. Check, R. Cohen. Marked improvement of vulvovaginitis of unknown origin in a pediatric patient - case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 723-724.
[14] J.H. Check, R. Cohen. Sympathomimetic amine therapy found effective for treatment of refractory chronic complex regional pain syndrome (reflex sympathetic dystrophy)[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(4): 478-482.
[15] J.H. Check, S. Chan. Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(2): 202-204.
No Suggested Reading articles found!